RCW
ELV icon

Rheos Capital Works’s Elevance Health ELV Stock Holding History

Rheos Capital Works’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-25,000
Closed -$9.72M – 69
2025
Q2 		$9.72M Hold
25,000
– – 0.56% 53
2025
Q1 		$10.9M Buy
25,000
+15,000
+150% +$6.02M 0.89% 40
2024
Q4 		$3.69M Hold
10,000
– – 0.2% 92
2024
Q3 		$5.2M Hold
10,000
– – 0.27% 95
2024
Q2 		$5.42M Buy
+10,000
New +$5.29M 0.28% 79

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Rheos Capital Works's ELV Position: Q3 2025 in Review

Rheos Capital Works sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 25,000 shares — an estimated $9.72M sold.

Rheos Capital Works first reported a position in ELV in Q2 2024 and held it in 5 quarters. The position peaked at $10.9M in Q1 2025. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • Rheos Capital Works reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • Rheos Capital Works sold 25,000 Elevance Health shares in Q3 2025, an estimated $9.72M.
  • Rheos Capital Works first reported a position in Elevance Health in Q2 2024 and held it in 5 quarters.
  • Rheos Capital Works's Elevance Health position peaked at $10.9M in Q1 2025.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Rheos Capital Works's 13F filing for Q3 2025, filed 22 Oct 2025.